Department of Anesthesiology
Author Title Type [ Year(Asc)]
Filters: Keyword is Succinylcholine  [Clear All Filters]
2010
Kopman AF, Lien CA, Naguib M.  2010.  Determining the potency of neuromuscular blockers: are traditional methods flawed? Br J Anaesth. 104(6):705-10.
2005
Lien CA, Belmont MR, Heerdt PM.  2005.  GW280430A: pharmacodynamics and potential adverse effects.. Anesthesiology. 102(4):861-2;authorreply862-3.
2004
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ.  2004.  Clinical pharmacology of GW280430A in humans.. Anesthesiology. 100(4):768-73.
Naguib M, Lien CA, Aker J, Eliazo R.  2004.  Posttetanic potentiation and fade in the response to tetanic and train-of-four stimulation during succinylcholine-induced block.. Anesth Analg. 98(6):1686-91,tableofcontents.
1999
Kopman AF, Klewicka MM, Kopman DJ, Neuman GG.  1999.  Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.. Anesthesiology. 90(2):425-31.
1997
Yao FS, Savarese JJ.  1997.  Pseudocholinesterase hyperactivity with succinylcholine resistance: an unusual cause of difficult intubation.. J Clin Anesth. 9(4):328-30.
1995
Savarese JJ, Lien CA, Belmont MR, Rubin L.  1995.  The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.. Acta Anaesthesiol Scand Suppl. 106:18-22.
Riker WF, Okamoto M, Artusio JF.  1995.  In vivo reversal of depolarizing neuromuscular blockade.. Arch Int Pharmacodyn Ther. 330(1):90-101.
1993
Kelly RE, Dinner M, Turner LS, Haik B, Abramson DH, Daines P.  1993.  Succinylcholine increases intraocular pressure in the human eye with the extraocular muscles detached.. Anesthesiology. 79(5):948-52.
1992
Okamoto M, Walewski JL, Artusio JF, Riker WF.  1992.  Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.. Anesth Analg. 75(3):361-71.
1980
Ramsey FM, Lebowitz PW, Savarese JJ, Ali HH.  1980.  Clinical characteristics of long-term succinylcholine neuromuscular blockade during balanced anesthesia.. Anesth Analg. 59(2):110-6.
Lebowitz PW, Savarese JJ.  1980.  Complications involving neuromuscular pharmacology.. Int Anesthesiol Clin. 18(3):139-56.
1979
D'Ambra MN, Dedrick D, Savarese JJ.  1979.  Kearns-Sayer syndrome and pancuronium--succinylcholine-induced neuromuscular blockade.. Anesthesiology. 51(4):343-5.
1978
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.
1976
Ali HH, Savarese JJ.  1976.  Monitoring of neuromuscular function.. Anesthesiology. 45(2):216-49.
1975
Fahmy NR, Gissen AJ, Savarese JJ, Kitz RJ.  1975.  Decamethonium and serum potassium in man.. Anesthesiology. 42(6):692-7.
Savarese JJ, Antonio RP, Ginsburg S.  1975.  Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.. Anesth Analg. 54(5):669-78.
Savarese JJ, Ali HH, Murphy JD, Padget C, Lee CM, Ponitz J.  1975.  Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine.. Anesthesiology. 42(1):106-11.
1973
Savarese JJ, Todd D.  1973.  Letter: Succinylcholine effects in anesthesia.. JAMA. 226(11):1359-60.
Savarese JJ, Ginsburg S, Lee SM, Kitz RJ.  1973.  The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications.. Anesth Analg. 52(6):982-8.
Savarese JJ, Kitz RJ.  1973.  The quest for a short-acting nondepolarizing neuromuscular blocking agent.. Acta Anaesthesiol Scand Suppl. 53:43-58.
1971
Ginsburg S, Kitz RJ, Savarese JJ.  1971.  Neuromuscular blocking activity of a new series of quaternary N-substituted choline esters.. Br J Pharmacol. 43(1):107-26.